Literature DB >> 844901

Immunoglobulin and specific-antibody synthesis in vitro by enteral and nonenteral lymphoid tissues after subcutaneous cholera immunization.

A M Svennerholm, J Holmgren.   

Abstract

An in vitro culture technique with synthesis of 14C-labeled protein has been used to study immunoglobulin and specific-antibody formation by spleen, mesenteric lymph nodes, Peyer's patches, and small intestine of rabbits, which were immunized twice subcutaneously with Vibrio cholerae lipopolysaccharide (LPS) and enterotoxin; saline-injected rabbits served as controls. Newly synthesized immunoglobulin G (IgG), IgA, and IgM were quantitated by liquid scintillation after their isolation by means of affinity chromatography from columns with immunoglobulin class-specific antibodies coupled to Sepharose. Specific antibodies were similarly measured after purification from gels derivatized with LPS or cholera toxin. The isolated antibodies had full biological activity as studied in protection tests. The immunization increased the overall IgM synthesis in the spleen. It also enhanced the production of IgA and IgG in Peyer's patches and of IgA in intestine. Significant synthesis of radiolabeled antibodies against both V. cholerae LPS and enterotoxin was found in spleen as well as in Peyer's patches of immunized animals. Titration with an enzyme-linked immunosorbent assay (ELISA) showed significant levels of IgG as well as IgA antibodies in incubation medium from all the studied tissues, whereas specific IgM was only found for spleen and mesenteric lymph nodes. Simultaneous tissue incubations at 37 degrees C and in an ice bath indicated that the major part of the antibodies registered with the ELISA represented de novo synthesis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 844901      PMCID: PMC421375          DOI: 10.1128/iai.15.2.360-369.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.

Authors:  A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

2.  "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin.

Authors:  A Forsgren; J Sjöquist
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

Review 3.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

4.  Experimental studies on cholera immunization. 1. The response of neutralizing and vibriocidal antibodies in rabbits after immunization with culture filtrate material from V. cholerae.

Authors:  J Holmgren; A M Svennerholm; O Ouchterlony
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

5.  Source and protective function of coproantibodies in intestinal disease.

Authors:  E S Fubara; R Freter
Journal:  Am J Clin Nutr       Date:  1972-12       Impact factor: 7.045

6.  Enzyme-linked immunosorbent assays for cholera serology.

Authors:  J Holmgren; A M Svennerholm
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

7.  Rabbit Peyer's patches, appendix, and popliteal lymph node B lymphocytes: a comparative analysis of their membrane immunoglobulin components and plasma cell precursor potential.

Authors:  S W Craig; J J Cebra
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

8.  Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.

Authors:  A M Svennerholm
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

9.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

10.  Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit.

Authors:  S W Craig; J J Cebra
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  9 in total

1.  Detection of antibodies to Mycoplasma pulmonis by an enzyme-linked immunosorbent assay.

Authors:  S A Horowitz; G H Cassell
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

Review 2.  Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells.

Authors:  K L Richards; S D Douglas
Journal:  Microbiol Rev       Date:  1978-09

3.  Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells.

Authors:  C Svanborg-Edén; A M Svennerholm
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

4.  Immune response of the ileum to invasive Escherichia coli diarrheal disease in rabbits.

Authors:  P D O'Hanley; J R Cantey
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

5.  Correlation between intestinal synthesis of specific immunoglobulin A and protection against experimental cholera in mice.

Authors:  A Svennerholm; S Lange; J Holmgren
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

6.  Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera.

Authors:  N F Pierce; W C Cray; B K Sircar
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

7.  Synergistic protective effect of antibodies against Escherichia coli enterotoxin and colonization factor antigens.

Authors:  C M Ahrén; A M Svennerholm
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

8.  Mesenteric Panniculitis Associated With Vibrio cholerae Infection.

Authors:  Grigory Roginsky; Andrew Mazulis; Jacob S Ecanow; Eli D Ehrenpreis
Journal:  ACG Case Rep J       Date:  2015-10-09

9.  Nonimmunoglobulin fraction of human milk inhibits bacterial adhesion (hemagglutination) and enterotoxin binding of Escherichia coli and Vibrio cholerae.

Authors:  J Holmgren; A M Svennerholm; C Ahrén
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.